Bosnia and Herzegovina vs Singapore: Deaths from cancer
Bosnia and Herzegovina
8,816 deaths
in 2021
Singapore
8,218 deaths
in 2021
Bosnia and Herzegovina rank
94th
Singapore rank
96th
Deaths from cancer over time
- Bosnia and Herzegovina
- Singapore
How they compare
Bosnia and Herzegovina currently reports 8,816 deaths against 8,218 deaths in Singapore, a difference of 598 deaths.
That makes Bosnia and Herzegovina's figure about 1.1 times Singapore's.
Across all 22 years both countries report, Bosnia and Herzegovina has been ahead every year.
Bosnia and Herzegovina ranks 94th and Singapore ranks 96th of 194 countries.
Bosnia and Herzegovina has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bosnia and Herzegovina | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7,994 deaths | 5,021 deaths | 2,972 deaths | Bosnia and Herzegovina |
| 2010s | 8,546 deaths | 6,890 deaths | 1,655 deaths | Bosnia and Herzegovina |
| 2020s | 8,969 deaths | 8,076 deaths | 892.51 deaths | Bosnia and Herzegovina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher deaths from cancer, Bosnia and Herzegovina or Singapore?
- Bosnia and Herzegovina, at 8,816 deaths against 8,218 deaths in Singapore as of 2021.
- What is the difference in deaths from cancer between Bosnia and Herzegovina and Singapore?
- 598 deaths, with Bosnia and Herzegovina ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Singapore?
- 22 years are reported by both, from 2000 to 2021.
- How do Bosnia and Herzegovina and Singapore rank globally for deaths from cancer?
- Bosnia and Herzegovina ranks 94th and Singapore ranks 96th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Deaths from cancer. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from malignant neoplasms in both sexes.